← SynDRA
AZILSARTAN
SynDRA canonical compound SYN0002686 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | AGTR2 |
|---|
| Mechanism of action | Angiotensin receptor antagonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Angiotensin receptor antagonist
- AGTR1 ANTAGONIST
- AGTR1 MODULATOR
Cross-references
Synonyms
- TAK-536
- Azilsartan (INN/USAN)
- TAK 536
- F9NUX55P23
- CHEBI:68850
- RefChem:54400
- DTXCID1086203
- MFCD20278186
- C25H20N4O5
- Azilsartan (TAK-536)
- TAK536
- Azilsartan [USAN]
- Azilsartan [USAN:INN]
- UNII-F9NUX55P23
- azilsartan?
- HSDB 8208
- Azilva (TN)
- Azilsartan (Standard)
- AZILSARTAN [MI]
- AZILSARTAN [INN]
- AZILSARTAN [JAN]
- Azilsartan Impurity 163
- AZILSARTAN [VANDF]
- AZILSARTAN [MART.]
- AZILSARTAN [WHO-DD]
- Azilsartan (JAN/USAN/INN)
- SCHEMBL167538
- SCHEMBL284893
- Azilsartan - Bio-X trade mark
- GTPL6901
- orb1309918
- SCHEMBL7097669
- Azilsartan, >=98% (HPLC)
- SCHEMBL29687472
- SCHEMBL30604716
- KGSXMPPBFPAXLY-UHFFFAOYSA-N
- GLXC-05169
- HMS3651J16
Reported adverse events
- Angioedema
- Hypotension
- Dizziness
- Fatigue
- Pruritus
- Loss of consciousness
- Rash
Look up AZILSARTAN in the interactive SynDRA portal →